In turn, Genetic variants in ABCC8 (SUR1) and KCNJ11 (Kir6.2) affect the function of ATP-sensitive potassium channels, modulating drug efficacy and the risk of hypoglycemia [32]. The gene discussed is KCNJ11; the disease is Hypoglycemia.